Acute myeloid leukemia (AML) is a cancer that affects the blood and bone marrow and is the most common type of acute leukemia in adults. With AML, the bone marrow (the center of the bone containing many blood vessels) makes abnormal white blood cells, red blood cells or platelets. Normally,…more.
- RWHC Home
- About RWHC
- Alzheimer’s Disease
- Amyotrophic Lateral Sclerosis
- Behavioral Health
- Movement Disorders
- Big Data
- Multiple Myeloma
- CAR-T Cell Therapy
- Non-Small Cell Lung Cancer
- Nonalcoholic Steatohepatitis
- COVID 19
- Pain Management
- Cystic Fibrosis
- Personalized Medicine
- Hepatitis C
- Secondary Progressive MS
- Macular Degeneration
Last March, as the COVID-19 pandemic started its relentless progression across the United States, hospitals and clinics nationwide closed their doors to all but the most gravely ill patients. While certain elective procedures and well visits were paused temporarily, patients with cancer didn’t have the luxury of waiting for things…more.
November is Lung Cancer Awareness Month, a time when the medical community, patients and their loved ones, advocacy organizations and industry come together to raise awareness and support for the number one cancer killer of men and women in the United States. Lung Cancer Trends For example, this year, the…more.
As the largest professionally led nonprofit network of cancer support worldwide, the Cancer Support Community (CSC), including its Gilda’s Club affiliates, is dedicated to ensuring that all people impacted by cancer are empowered by knowledge, strengthened by action, and sustained by community. CSC achieves its mission through three areas: direct…more.
Editor’s Note: This week, Real World Health Care shares an inspirational story of a woman who was diagnosed with lymphoma and received treatment with CAR T-cell therapy. “CAR-T Cell Therapy Gave Me My Life Back” is reprinted with permission from the Association of Community Cancer Centers. Updated in April 2020,…more.
CAR T-cell therapy (CAR-T) has emerged as a highly innovative and promising option for patients with cancer. Until recently, the use of CAR-T has been restricted to small clinical trials, primarily with patients with advanced blood cancers. These trials often are conducted at large, academic medical centers in major metropolitan…more.
Editor’s Note: The following article is reprinted, with permission from Biotech Primer. The original version appeared in the Biotech Primer WEEKLY. To subscribe to the Biotech Primer WEEKLY, click here. The first (and so far, only) chimeric antigen receptor T-cell (CAR-T) therapies—tisagenlecleucel and axicabtagene ciloleucel were approved in 2017, and…more.
At the Cancer Support Community, we have always strived to serve everyone who has been affected by cancer. For us, this means providing support to patients as well as their family members, who often play a critical role in providing support and care. It also means conducting research that prioritizes…more.
Being the primary caregiver to a cancer patient is a long, intense experience both physically and emotionally. The cancer caregiver often experiences all the highs and lows of the patient’s cancer journey and is there to observe every detail, for better or for worse. This makes the caregiver a beacon…more.
By definition, parents are their child’s number one caregiver. However, when that child has cancer, “caregiving” takes on a completely new meaning and many new challenges. Consider the journey: A child is born, and the proud parents wait for a little cry. They count ten fingers and ten toes and…more.